Medistep Healthcare IPO Listing at 4% Premium at ₹103 Per Share

Posted by : sachet | Mon Aug 18 2025

Medistep Healthcare IPO listing: The Medistep Healthcare IPO was subscribed 382.14 times till its closing. In this subscription, [.] times were received by the qualified institutional buyers (QIBs) and 289.15 times by non-institutional investors (NIIs). The retail quota of the issue was subscribed to 47.52%. Before delving deeper into the topic, go through the details of the Medistep Healthcare IPO.

Table of Contents

Medistep Healthcare IPO Listing

On the NSE and SME platform, Medistep Healthcare Limited is listed at ₹53 per share at a premium of 23% against the issue price of ₹43 per share.

About Medistep Healthcare IPO Details

Medistep Healthcare IPO: It is a bookbuilding IPO of ₹16.10 crore, comprising a fresh issue of 37.44 lakh shares. The issue will be listed on NSE and SME on its tentative listing date, 18th August 2025. The Medistep Healthcare IPO date is fixed between 8th August 2025 and 12th August 2025. The face value of Medistep Healthcare IPO shares stands at ₹10 per share, and the IPO price is set at ₹43 per share.

IPO Open Date	8th August 2025
IPO Close Date	12th August 2025
IPO Allotment Date	13th August 2025
Refund Initiation	14th August 2025
Issue Size	37,44,000 shares(aggregating up to ₹16.10 Cr)
Face Value	₹10 per share
Lot Size	3,000 Shares
Issue Price Band	₹43 per share
Issue Type	Bookbuilding IPO
Listing At	NSE & SME
Listing Date	18th August 2025

About Medistep Healthcare Limited

Medistep Healthcare Limited was incorporated in june 2023.Medistep Healthcare Limited is a pharmaceutical company that offers a variety of health products that include sanitary pads, pharmaceutical products, nutraceutical products, personal care products, and surgical products. The company has a strong commitment towards excellence, high productivity, and a focus on delivering innovative healthcare products. Medistep Healthcare Limited has raised funds through its IPO for the expansion of its production capacity, innovative production, technology advancement, and quality assurance.

Medistep Healthcare Limited Financials

The company’s financial analysis is essential before applying for the Medistep Healthcare IPO. Look at the table to learn about Medistep Healthcare Limited’s financials.

Year Ended	31st March 2025 (in cr.)	31st March 2024 (in cr.)	31st March 2023 (in cr.)
Assets	22.99	14.96	14.66
Revenue	49.66	31.63	27.44
Profit After Tax	4.14	2.91	0.92
EBITDA	5.60	3.96	1.34
Net Worth	16.83	11.69	1.07
Reserve and surplus	6.37	6.79	–
Total Borrowing	0.64	0.33	0.53

Explanation

Medistep Healthcare Limited’s revenue increased by 57% from ₹31.63 crores in March 2024 to ₹49.63 crores in March 2025. Moreover, the company’s PAT increased by 42% from ₹2.91 crores to ₹4.14 crores. Investors can analyse other relevant factors and make a decision accordingly.